Skip to main content
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
letter
. 1990 Mar;83(3):197–198. doi: 10.1177/014107689008300331

Thrombolysis for acute myocardial infarction.

J Norman, P Magill
PMCID: PMC1292582  PMID: 2325068

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Stampfer M. J., Goldhaber S. Z., Yusuf S., Peto R., Hennekens C. H. Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomized trials. N Engl J Med. 1982 Nov 4;307(19):1180–1182. doi: 10.1056/NEJM198211043071904. [DOI] [PubMed] [Google Scholar]
  2. Van de Werf F., Arnold A. E. Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction. BMJ. 1988 Nov 26;297(6660):1374–1379. doi: 10.1136/bmj.297.6660.1374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES